Eli Lilly's Antibody Reduces COVID-19 Risk by 80% in Nursing Homes

Eli Lilly's Antibody Reduces COVID-19 Risk by 80% in Nursing Homes

Results of a clinical trial suggest pre-emptive treatment with bamlanivimab can prevent COVID-19 from spreading through nursing homes.